SHIJIAZHUANG CANSAV PHARMACEUTICAL TECHNOLOGY CO LTD

SHIJIAZHUANG CANSAV PHARMACEUTICAL TECHNOLOGY CO LTD (China) holds 17 active US FDA Type II Drug Master Files and has DMF or CEP filings on record for 12 active ingredients. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “SHIJIAZHUANG CANSAV PHARMACEUTICAL TECHNOLOGY CO LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/shijiazhuang-cansav-pharmaceutical-technology-co-ltd

Overview

SHIJIAZHUANG CANSAV PHARMACEUTICAL TECHNOLOGY CO LTD is an active pharmaceutical ingredient (API) supplier with 17 active FDA Type II Drug Master Files, covering AMBROXOL HYDROCHLORIDE; ASCORBYL GLUCOSIDE; BENIDIPINE HYDROCHLORIDE; BROENAC SODIUM; CHLORZOXAZONE; FINERENONE.

Core services & business areas

API Manufacturing

Active ingredients with DMF or CEP filings

Substances for which SHIJIAZHUANG CANSAV PHARMACEUTICAL TECHNOLOGY CO LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

SHIJIAZHUANG CANSAV PHARMACEUTICAL TECHNOLOGY CO LTD holds 17 active (17 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • ASCORBYL GLUCOSIDEActive2026-03-25
  • RECOMBINANT PROTEIN A/G/LActive2026-02-12
  • FINERENONEActive2026-01-26
  • GLYCOSYLGLYCEROLActive2025-11-28
  • SUCROSE PHOSPHORYLASEActive2025-11-28
  • SUMO PROTEASEActive2025-09-22
  • MENAQUINONE-4Active2024-11-25
  • CHLORZOXAZONEActive2024-11-22
  • LIDOCAINE HYDROCHLORIDEActive2024-11-19
  • BROMFENAC SODIUMActive2024-11-14
  • TRIBENOSIDEActive2024-11-14
  • KETOROLAC TROMETHAMINEActive2024-11-13
  • LEVOCARNITINEActive2024-11-11
  • AMBROXOL HYDROCHLORIDEActive2024-11-11
  • MECOBALAMINActive2024-11-10
  • LIDOCAINEActive2024-11-10
  • BENIDIPINE HYDROCHLORIDEActive2024-11-07

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to SHIJIAZHUANG CANSAV PHARMACEUTICAL TECHNOLOGY CO LTD in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this SHIJIAZHUANG CANSAV PHARMACEUTICAL TECHNOLOGY CO LTD?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.